Invention Grant
- Patent Title: MAGL inhibitors
-
Application No.: US17055079Application Date: 2019-05-14
-
Publication No.: US11332453B2Publication Date: 2022-05-17
- Inventor: Cheryl A. Grice , Daniel J. Buzard , Michael B. Shaghafi
- Applicant: H. Lundbeck A/S
- Applicant Address: DK Valby
- Assignee: H. Lundbeck A/S
- Current Assignee: H. Lundbeck A/S
- Current Assignee Address: DK Valby
- Agency: Wilson Sonsini Goodrich & Rosati
- International Application: PCT/US2019/032289 WO 20190514
- International Announcement: WO2019/222266 WO 20191121
- Main IPC: C07D295/185
- IPC: C07D295/185 ; C07D305/06 ; C07D263/32 ; C07D241/12 ; C07D213/55 ; C07D305/08
Abstract:
Provided herein are piperazine carbamates and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful as modulators of MAGL. Furthermore, the subject compounds and compositions are useful for the treatment of pain.
Public/Granted literature
- US20210206735A1 MAGL INHIBITORS Public/Granted day:2021-07-08
Information query
